Full-Time

Distinguished Software Engineer

Int

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Compensation Overview

$260k - $285kAnnually

+ Annual Cash Bonus + New Hire Equity + Annual Refresh

Senior, Expert

Seattle, WA, USA

70% in-office structure required.

Category
Full-Stack Engineering
Software Engineering
Required Skills
Data Structures & Algorithms
Requirements
  • Bachelor’s degree in Computer Science, Engineering, or a related field; advanced degree preferred.
  • 10+ years of experience as a software engineer
  • 5+ years of experience working on large, complex projects in a technical leadership capacity.
  • 5+ years of proven experience in designing, building, and operating complex software systems, preferably in the biotechnology or pharmaceutical industry.
  • Proven expertise in designing and building complex distributed systems.
  • Deep hands-on technical expertise in large-scale full stack development and building complex distributed systems.
  • Strong knowledge of object-oriented design, data structures, and algorithms.
Responsibilities
  • Break down complex problems into simple, straightforward solutions, understanding system interdependencies and limitations.
  • Drive the technical vision by providing expert knowledge in performance, multi-tenancy, scalability, enterprise system architecture, and engineering best practices, and guide teams in delivery.
  • Provide overall architectural guidance for engineering initiatives, while establishing principles, frameworks, and standards to promote the adoption of the best engineering practices.
  • Manage major technical incidents, minimizing downtime and impact while implementing strategic corrective actions to prevent future recurrences.
  • Balance technical leadership with strong business judgment to make the right decisions about technology choices for the use case.
  • Help the engineering team deliver excellent results through rapid iterations and cultivate engineering and operational excellence through metrics and continuous learning.
  • Scale yourself through comprehensive documentation.
  • Represent the company at technical conferences, industry events, and in interactions with partners and customers, promoting Moderna's technical expertise and thought leadership.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial molecule that provides instructions for cells to produce proteins necessary for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?